The General Pharmaceutical Council (GPhC) and the Chief Pharmaceutical Officer for England have written a letter to pharmacy professionals thanking them for
providing the best possible services to patients and the public, despite experiencing high and sustained demands and pressures.
GPhC Chief Executive Duncan Rudkin and CPhO David Webb indicated that there will be further challenges over the coming weeks and months due to the ongoing industrial
action, and staff shortages due to sickness or caring responsibilities.
They expressed concerned that increased pressure will have a significant and potentially prolonged impact on pharmacy teams both personally and professionally.
Acknowledging that pharmacy professionals may have to make some difficult decisions as they deal with the pressures they face, the leaders have urged those working
in pharmacy to use "your professional judgement to assess and mitigate risk, and to deliver safe and effective care for your patients within your scope of practice."
The Department of Health and Social Care (DHSC) will introduce new arrangements for the setting of Drug Tariff Category A reimbursement prices from April 2024.
Driven by ministers, DHSC's decision aims to equalise access to margin on Category A medicines and it's part of a series of drug reimbursement reforms proposed by
the department following a public consultation in 2019.
Currently, prices of medicines in Category A are subject to monthly adjustment. From 1 April 2024, these will be updated quarterly based on sales and volume data
obtained by DHSC under the Health Service Products (Provision and Disclosure of Information) Regulations 2018. The transition will conclude in July 2025 when the reimbursement prices will be exclusively determined by the new method.
Advance notice for contractors regarding the 'new arrangements' has been outlined on the NHSBSA website.
However, Community Pharmacy England (CPE) did not support the introduction of the changes at this time as pharmacies are currently grappling with "wider challenges"
and there is uncertainty about the potential impact of these changes on the already "turbulent" medicines supply chain
The National Health Service (NHS) is embracing new technology and innovations like artificial intelligence (AI) to reduce the number of missed hospital
appointments and improve waiting times for elective care.
Following a successful pilot in Mid and South Essex NHS Foundation Trust, the health service is set to roll out AI software to 10 more trusts across England in
the coming months.
The software, developed by Deep Medical in collaboration with a frontline worker and NHS clinical fellow, helps reduce the number of missed appointments by
offering patients convenient time slots and backup booking options.
Since the AI programme was piloted six months ago, Mid and South Essex NHS Foundation Trust has seen a 30 per cent fall in non-attendances.
During the pilot period, a total of 377 did not attends (DNAs) were prevented and an additional 1,910 patients were attended.
The number of people living to be 100 or more increased by 3.7 per cent in England and Wales in 2022, compared to the previous year, according to new
figures from the Office for National Statistics (ONS).
ONS data also revealed that the number of centenarians in the UK has more than doubled in the last two decades.
Wales has more centenarians (27 people per 100,000 aged 100 or over) than England (25 people per 100,000).
It's good news that more people are living into their second century, but it also means that we may need to rethink our health plans for a longer future, a leading
testing expert has suggested.
The 14th Community Pharmacy Conference by Sigma Pharmaceuticals has been timely, prime minister Rishi Sunak said, noting that it coincided with the launch
of Pharmacy First, a new initiative that enables patients to receive treatments for seven common conditions directly from a pharmacist without the need for a GP
appointment or prescription.
"We are all grateful for the tremendous contributions that pharmacists make to our NHS. The fantastic work you do is critical to the success of Pharmacy First and
many other initiatives," Sunak said in a written message.
The conference was organised from 25-29 February at Sun City in Johannesburg, South Africa, under the theme 'community pharmacy in an integrated NHS'.
In a recorded video address to the Sigma Conference, shadow health secretary Wes Streeting said community pharmacies are 'critical' to the Labour party's mission to
make the NHS 'fit for the future'.
"You should be playing a much more significant role. Labour's reform agenda will get pharmacists working to the top of their licence. We want community pharmacists
to play a greater role in healthcare, with more focus on their expertise in prescribing and medicines management," he said.
The severity of the ADHD medication shortage in the UK has been exposed as former Hollywood extra Lee Cato revealed that he was forced to quit his job but
hasn't been able to access his medicine.
A resident of Berkhamsted, Hertfordshire, Lee had worked as a film extra in big movies like 'Thor' and 'Edge of Tomorrow'.
The 48-year-old told Mirror that he has been taking Concerta for years to manage ADHD symptoms, but he hasn't been able to get the drug or any alternatives for
over a month.
He said that he first experienced shortages of the medicine in December 2023 but was initially able to take Delmosart, which he took to maintain focus despite
experiencing its side effects such as headaches, nausea, tooth erosion, and a dry mouth.
But now, he can't get access to any of these ADHD drugs as "they're completely out-of-stock and it's been over a month now."
His chemist also tried to get hold of his medication but failed.
Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness
through a second year of respiratory disease season.
The company said in a press release that the vaccine's efficacy against RSV-associated lower respiratory tract disease with three or more symptoms was 77.8 per cent
through season two, compared with efficacy of 88.9 per cent after the first RSV season, which led to the shot's US approval.
The data is from a late-stage trial of more than 37,000 participants being conducted in both the Northern and Southern hemispheres.
Cumulative efficacy over both seasons after around 16.4 months of disease surveillance was 81.5 per cent, Pfizer said.
The data is similar to the efficacy of GSK's rival RSV shot Arexvy over two seasons, which was released in June.
Responding to an MP's question in the House of Commons, prime minister Rishi Sunak reiterated his deep concern for the future of UK community pharmacies,
stressing their commitment to enhancing the sector with an additional £645 million in funding through the Pharmacy First initiative.
At the recent Prime Minister's Questions last Wednesday, Angela Richardson, the Conservative MP for Guildford, raised the issue of rising pharmacy closures,
revealing that Guildford recently lost two neighbouring pharmacies.
Highlighting that empowering local pharmacies is a key part of this government's plan to cut waiting lists, she asked Sunak whether he would agree that it is
vital for residents to have access to "a good, efficient, and above all, local pharmacy."
In response, Sunak said: "I care deeply about the future of our community pharmacies."
In his first speech as Secretary of State for Health and Social Care, Wes Streeting MP acknowledged that the NHS is in crisis while outlining his mission to
save the health service.
Streeting described the current state of the NHS as "broken," noting its failure to meet the needs of both patients and dedicated healthcare professionals.
"When we said during the election campaign, that the NHS was going through the biggest crisis in its history, we meant it.
"When we said that patients are being failed on a daily basis, it wasn't political rhetoric, but the daily reality faced by millions," he said on Friday (5 July).
The new health secretary remarked that previous governments had been unwilling to admit these simple facts.